Euroapi S.A.S.U. is a leading pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs) and intermediates for human and veterinary medicines. With approximately 200 products in its portfolio, it offers one of the largest selections in the industry, leveraging advanced technologies such as solid phase chemistry, particle engineering, microbial fermentation, small molecule synthesis, prostaglandins, steroids, hormones, opiates, controlled substances, and lipids. Euroapi serves a broad range of clients including pharmaceutical firms, generic drug manufacturers, biotechnology companies, animal health product makers, consumer health, nutrition, cosmetic product companies, and contract development manufacturing organizations. Positioned as a critical player in the healthcare sector, particularly in drug manufacturers—specialty and generic—it supports global pharmaceutical innovation, regulatory compliance, and supply chain efficiency from its base in Paris, France, where it was incorporated in 2020 and employs around 3,187 people.